The Rakuten-backed social media company, which was valued at more than $12bn in 2017, has filed to list on the New York Stock Exchange.
Month: March 2019
Ke collects Tencent on its way to $800m
The Lianjia spinoff is currently raising $800m in a series D round that will be led by Tencent, and which looks likely to be its first external funding.
Carbon Engineering unearths $68m
Chevron, Occidental Petroleum, BHP and Bethel Lands all invested in a round that will fund further testing of Carbon Enginnering’s carbon capture technology.
Pfizer visits Vivet with $51m
Pharmaceutical firm Pfizer has acquired a 15% stake in the gene therapy developer along with an exclusive option to fully buy the Novartis-backed company.
Movius dials in $45m series D
The communication software developer boosted its total funding to $91m in a round that included Anschutz Investment Company.
GenoImmune generates series A financing
The immunotherapy developer, which is majority owned by BGI Group, has secured $17.8m in a GF Securities-led round that will fund clinical work on its lead product candidate.
VPS charges up $17m series B
The data centre technology developer will put the proceeds from the CUI-led round into its marketing and research and development activities.
Brainlab concludes Medineering acquisition
Brainlab has purchased the surgical robotics technology provider for an undisclosed amount, two years after investing in the company.
BioLeaders brings $10m for Weizmann spinout
BioLeaders is investing $10m in an as yet unnamed spinout from Weizmann Institute of Science working on a genetic drug for cancer.
News round up March 25 2019
A round up of all the news on www.globalcorporateventuring.com for our subscribers.
Tepper takes off from GE Ventures
Alex Tepper has departed from a managing director position at General Electric’s corporate VC unit to take a senior managing director role at startup studio Human Ventures.
TCM hires ex-JLabs lead Tom Luby
The former head of Johnson & Johnson’s JLabs@TMC incubator has been appointed director of Texas Medical Center’s TMC Innovation Institute.
Humana’s Burr to hang with Mr Cooper
Busy Burr, a founding partner of Humana Health Ventures who featured on GCV’s 2017 and 2018 Powerlists, was named a director at Mr Cooper at the end of February.
Analysis: Ride hailing IPOs
The two rivalling US-based ride hailing platforms Uber and Lyft, both counting many corporates among their backers, are preparing to float on public markets in the coming weeks, with the
valuations of the two combined likely to stand well above $100bn